CLIMB BIO INC (CLYM) Stock Cash Flow
NASDAQ:CLYM - Nasdaq - US28658R1068 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -73.90M | -35.12M | -45.24M | -47.48M | -20.67M | |||
| Change In Working Capital | 1.70M | 3.76M | 210.00K | -4.17M | -2.94M | |||
| Other non cash items | 56.64M | 10.76M | 7.67M | 15.58M | 9.51M | |||
| OPERATING CASH FLOW | -15.56M | -20.60M | -37.37M | -36.07M | -14.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.64M | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | -116.45M | 68.98M | 34.44M | -114.97M | 8.08M | |||
| INVESTING CASH FLOW | -121.09M | 68.98M | 34.44M | -114.97M | 8.08M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 130.73M | 841.00K | 0.00 | 177.23M | 4.93M | |||
| FINANCING CASH FLOW | 130.73M | 841.00K | 0.00 | 177.23M | 4.93M | |||
| Exchange Rate Effect | 42.00K | 304.00K | -410.00K | 250.00K | 360.00K | |||
| CHANGE IN CASH | -5.88M | 49.53M | -3.34M | 26.44M | -730.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.56M | -20.60M | -37.37M | -36.07M | -14.10M | |||
| Capital Expenditure | -4.64M | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -20.21M | -20.60M | -37.37M | -36.07M | -14.10M | |||
All data in USD